In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Sana Biotechnology (SANA – Research ...
On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.39 which represents a decrease of $-0.37 or -9.84% from the prior close of $3.76. The stock opened at $3.5 and ...
Fintel on MSN1d
JMP Securities Downgrades Sana Biotechnology (SANA)Fintel reports that on November 5, 2024, JMP Securities downgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from ...
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 ...
JMP has downgraded Sana Biotechnology (NASDAQ:SANA) to market perform from market outperform, citing uncertainty surrounding ...
Just three years removed from a lucrative IPO, the company will cut jobs for a third time and invest more heavily in cell ...
JMP Securities downgraded Sana Biotechnology (SANA) to Market Perform from Outperform without a price target after the company announced a ...
Sana Biotechnology is pruning its pipeline and headcount for the second time in around a year to stretch its cash and ...
Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a ...
PARSIPPANY, NJ, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace” or the "Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended September 30, ...
It’s not just investments that are gaining traction. Recent approvals are changing the game, with Iovance and Adaptimmune ...
Luxury skincare and professional spa brand Germaine de Capuccini has developed a new pro-ageing night serum called Retinight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback